DK1330253T3 - Anvendelse af bioaktiv fraktion af kourindestillat ("Go-mutra") som en biofremmer for antiinfektionsmidler, anticancermidler og næringsmidler - Google Patents

Anvendelse af bioaktiv fraktion af kourindestillat ("Go-mutra") som en biofremmer for antiinfektionsmidler, anticancermidler og næringsmidler

Info

Publication number
DK1330253T3
DK1330253T3 DK00990873T DK00990873T DK1330253T3 DK 1330253 T3 DK1330253 T3 DK 1330253T3 DK 00990873 T DK00990873 T DK 00990873T DK 00990873 T DK00990873 T DK 00990873T DK 1330253 T3 DK1330253 T3 DK 1330253T3
Authority
DK
Denmark
Prior art keywords
bio
distillate
courine
mutra
infectives
Prior art date
Application number
DK00990873T
Other languages
English (en)
Inventor
A K Shasany
J S Arya
S B Mansinghka
S H Dawle
S P S Khanuja
S Kumar
M P Darokar
M Singh
P Sinha
S Awasthi
S C Gupta
V K Gupta
M M Gupta
R K Verma
S Agarwal
Original Assignee
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res
Application granted granted Critical
Publication of DK1330253T3 publication Critical patent/DK1330253T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK00990873T 2000-10-20 2000-10-20 Anvendelse af bioaktiv fraktion af kourindestillat ("Go-mutra") som en biofremmer for antiinfektionsmidler, anticancermidler og næringsmidler DK1330253T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2000/000106 WO2002032436A1 (en) 2000-10-20 2000-10-20 Use of bioactive fraction from cow urine distillate ('go mutra') as a bio-enhancer of anti-infective, anti-cancer agents and nutrients

Publications (1)

Publication Number Publication Date
DK1330253T3 true DK1330253T3 (da) 2004-10-04

Family

ID=11076279

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00990873T DK1330253T3 (da) 2000-10-20 2000-10-20 Anvendelse af bioaktiv fraktion af kourindestillat ("Go-mutra") som en biofremmer for antiinfektionsmidler, anticancermidler og næringsmidler

Country Status (11)

Country Link
EP (1) EP1330253B1 (da)
KR (1) KR100848394B1 (da)
CN (2) CN1234372C (da)
AT (1) ATE273014T1 (da)
AU (3) AU2001230486B2 (da)
BR (1) BR0017342A (da)
CA (1) CA2425025C (da)
DE (1) DE60012996T2 (da)
DK (1) DK1330253T3 (da)
MX (1) MXPA03002653A (da)
WO (1) WO2002032436A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003226643A1 (en) * 2003-03-31 2004-10-25 Council Of Scientific And Industrial Research A composition (rucd) for protecting and/or repairing dna from oxidative damages and a method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3248295A (en) * 1962-12-26 1966-04-26 Canadian Patents Dev Anti-allergic urine extract and method of making same
KR100523463B1 (ko) * 2003-05-30 2005-10-25 영남대학교 산학협력단 노루오줌 추출물 또는 이로부터 분리된 아스틸빅산 및펠토보이키놀릭산 유도체를 함유하는 항염증 또는항알러지 조성물

Also Published As

Publication number Publication date
CA2425025C (en) 2010-11-23
CN1234372C (zh) 2006-01-04
CN100536856C (zh) 2009-09-09
CA2425025A1 (en) 2002-04-25
AU2001230486B2 (en) 2005-11-10
EP1330253B1 (en) 2004-08-11
DE60012996T2 (de) 2005-01-27
WO2002032436A1 (en) 2002-04-25
AU3048601A (en) 2002-04-29
CN1788735A (zh) 2006-06-21
AU2005237162B2 (en) 2007-02-08
KR100848394B1 (ko) 2008-07-24
ATE273014T1 (de) 2004-08-15
MXPA03002653A (es) 2004-01-29
EP1330253A1 (en) 2003-07-30
BR0017342A (pt) 2004-02-03
CN1454092A (zh) 2003-11-05
DE60012996D1 (de) 2004-09-16
AU2005237162A1 (en) 2005-12-22
KR20040015010A (ko) 2004-02-18

Similar Documents

Publication Publication Date Title
DE69837809D1 (de) Apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dislipidemischer erkrankungen
BR0309875A (pt) métodos e composições para tratamento de distúrbios do sistema nervoso periférico e novos compostos úteis para isto
ZA200405657B (en) Formulation & dosage form for the controlled delivery of therapeutic agents.
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
CA2359510A1 (en) .omega.-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
SE0101675D0 (sv) Novel composition
NO20042298L (no) Farmasoytiske preparater og deres anvendelser
GB0102687D0 (en) Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them
PL360262A1 (pl) Kompozycje polimerycznych micelli
ATE556713T1 (de) Omega-carboxyarylsubstituierte-diphenyl- harnstoffe als p38-kinasehemmer
WO2005079195A3 (en) Pyrazolopyridines and analogs thereof
BR0314797A (pt) Derivados da pirimidineamida e o uso dos mesmos
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
UY26130A1 (es) Compuestos para tratar la obesidad
BR0210028A (pt) Agentes antibacterianos
ATE345775T1 (de) Zusammensetzungen zur verabreichung von arzneimittelkombinationen
DK1057828T3 (da) Orale trovafloxacin-suspensioner
BR0113590A (pt) 7-oxo-piridopirimidinas
BRPI0508107A (pt) derivados de indazol e composições farmacêuticas contendo os mesmos
WO2005117895A8 (en) Compositions comprising meloxicam
MXPA04005809A (es) Inhibidores de proteinas quinasas.
EP1501497A4 (en) CATECHIN MULTIMES THAN THERAPEUTIC DRUGS SUBSTITUTES
ATE253359T1 (de) Antithrombotische mittel
PT1355906E (pt) Derivados de 2h-1-benzopirano processos para a sua preparacao e as suas composicoes farmaceuticas
WO2004006830A3 (en) Use of ccn protein family members for the treatment of disorder associated to an altered calcium and/or sodium flux